샘플 요청 목록

 카트 문의
시장보고서
상품코드
1631239

생체 임피던스 분광법 시장 - 세계 업계 분석, 규모, 점유율, 성장, 동향, 예측(2032년)

Bioimpedance Spectroscopy Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2032
발행일: | 리서치사: Fairfield Market Research | 페이지 정보: 영문 185 Pages | 배송안내 : 2-5일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

생체 임피던스 분광법(BIS) 시장은 비침습적 진단과 맞춤형 의료로 의료가 전환됨에 따라 혁신적인 성장세를 보이고 있으며, BIS는 생체 조직의 임피던스를 측정하여 체액 분포와 조직 구성에 대한 정보를 제공합니다. BIS 시장 규모는 연평균 12.70%의 CAGR로 성장하여 2025년 5억 7,000만 달러에서 2032년 13억 1,980만 달러에 달할 것으로 예상됩니다.

BIS 시장은 연평균 12.70%의 CAGR을 달성할 것으로 예상되며, 헬스케어 및 소비자 웰빙 분야에서의 채택 확대가 큰 폭의 성장을 견인할 것으로 예상되며, BIS 기술에 대한 수요는 정밀 의료 및 예방 의료를 향한 세계 트렌드를 강조하고 있습니다.

생체 임피던스 분광법 시장은 헬스케어 및 소비자 응용 분야로의 통합이 진행됨에 따라 지속적인 성장이 예상됩니다. 연구 개발, 웨어러블 기술 개발 및 세계 협력에 대한 전략적 투자는 현재의 과제를 해결하고 BIS의 잠재력을 극대화하기 위해 매우 중요합니다. 비침습적 진단에 대한 수요가 증가함에 따라 BIS는 정밀의료와 예방의료의 미래를 형성하는 데 중요한 역할을 할 것으로 보입니다.

심혈관질환과 암의 유병률 증가는 BIS와 같은 첨단 진단 도구에 대한 수요를 강조하고 있습니다. BIS는 조기에 정확한 진단이 가능하기 때문에 만성질환 관리에 필수적인 솔루션입니다. 비침습적이고 실시간 모니터링 도구는 의료 시스템이 예방 의료를 중시하는 가운데 비침습적이고 실시간 모니터링 도구가 필수적이며, BIS는 실시간의 실용적인 인사이트를 제공하는 능력으로 그 보급을 뒷받침하고 있습니다. 피트니스 애호가들이 점점 더 많이 사용하고 있으며, 맞춤형 피트니스 계획과 성능 향상을 가능하게 하고 있습니다. BIS의 소형화 혁신과 웨어러블 기기에의 통합은 POC(Point-of-Care) 애플리케이션의 새로운 기회를 열어 진단을 보다 친숙하고 효율적으로 만들 수 있습니다.

세계의 생체 임피던스 분광법 시장에 대해 조사했으며, 시장 개요와 함께 제품별, 모달리티별, 최종사용자별, 지역별 동향, 시장 진입 기업의 경쟁 동향 등의 정보를 정리하여 전해드립니다.

목차

제1장 주요 요약

제2장 시장 개요

  • 시장 정의와 세분화
  • 시장 역학
  • 밸류체인 분석
  • Porter's Five Forces 분석
  • COVID-19의 영향 분석
  • 우크라이나·러시아 분쟁의 영향
  • 경제 개요
  • PESTLE 분석

제3장 2024년 가격 분석

제4장 세계의 생체 임피던스 분광법 시장 전망, 2019-2032년

  • 세계의 생체 임피던스 분광법 시장 전망, 제품별, 금액(10억 달러), 수량(건), 2019-2032년
  • 세계의 생체 임피던스 분광법 시장 전망, 모달리티별, 금액(10억 달러, 2019-2032년)
  • 세계의 생체 임피던스 분광법 시장 전망, 최종사용자별, 금액(10억 달러, 2019-2032년)
  • 세계의 생체 임피던스 분광법 시장 전망, 지역별, 금액(10억 달러), 수량(건), 2019-2032년

제5장 북미의 생체 임피던스 분광법 시장 전망, 2019-2032년

제6장 유럽의 생체 임피던스 분광법 시장 전망, 2019-2032년

제7장 아시아태평양의 생체 임피던스 분광법 시장 전망, 2019-2032년

제8장 라틴아메리카의 생체 임피던스 분광법 시장 전망, 2019-2032년

제9장 중동 및 아프리카의 생체 임피던스 분광법 시장 전망, 2019-2032년

제10장 경쟁 구도

  • 기업 시장 점유율 분석, 2024년
  • 경쟁 대시보드
  • 기업 개요
    • Tanita Corporation
    • Akern
    • Biodynamics Corporation
    • Bioparhom
    • Biotekna
    • Bodystat Ltd
    • Charder Electronic Co. Ltd
    • Evolt 360
    • Fook Tin Group Holding Ltd
    • InBody Co. Ltd
    • Lumsail Industrial Inc.
    • Maltron International
    • Omron Corporation
    • RJL Systems
    • Seca GmbH & Co. KG

제11장 부록

ksm 25.02.04

The Bioimpedance Spectroscopy (BIS) market is undergoing transformative growth as healthcare shifts towards non-invasive diagnostics and personalized medicine. BIS measures biological tissue impedance across frequencies, offering insights into fluid distribution and tissue composition. Applications span from chronic disease management to sports medicine, making BIS a cornerstone in modern healthcare.The BIS market is forecasted to grow at a compound annual growth rate (CAGR) of 12.70%, with an estimated market value of USD 570 million by 2025 and USD 1,319.8 million by 2032.

Market Overview

The BIS market is projected to achieve a compound annual growth rate (CAGR) of 12.70%, with substantial growth driven by increasing adoption in healthcare and consumer wellness sectors. The demand for BIS technologies highlights the global trend toward precision and preventive medicine.

The bioimpedance spectroscopy market is poised for continued growth as it integrates into broader healthcare and consumer applications. Strategic investments in R&D, wearable technology development, and global collaborations are pivotal to addressing current challenges and unlocking the full potential of BIS. With increasing demand for non-invasive diagnostics, BIS is set to play a vital role in shaping the future of precision and preventive healthcare.

Key Drivers

  • Chronic Disease Management: The rising prevalence of cardiovascular diseases and cancer underscores the demand for advanced diagnostic tools like BIS. Its ability to provide early and precise diagnostics positions it as a critical solution in managing chronic diseases.
  • Preventive Healthcare: As healthcare systems emphasize preventive care, non-invasive and real-time monitoring tools are becoming essential. BIS's ability to deliver actionable insights in real-time supports its widespread adoption.
  • Fitness and Sports Applications: BIS is increasingly being used by athletes and fitness enthusiasts for advanced body composition analysis and hydration monitoring, enabling customized fitness plans and improved performance.
  • Technological Advancements: Innovations in miniaturization and the integration of BIS in wearable devices open new opportunities for point-of-care applications, making diagnostics more accessible and efficient.

Opportunities

  • Expanding Clinical Applications: Beyond traditional areas like oncology and lymphedema management, BIS shows potential in neurology, nephrology, and metabolic disorders. These expanding applications offer significant revenue opportunities for market players.
  • Wearable Technology Integration: Embedding BIS sensors in fitness trackers and smartwatches creates new possibilities for real-time health monitoring, appealing to both consumers and healthcare providers.
  • Strategic Collaborations: Partnerships between BIS manufacturers, healthcare institutions, and research organizations can drive innovation and broaden the scope of BIS applications.

Challenges

  • Regulatory Barriers: The diverse regulatory Analysis across regions poses challenges for BIS device manufacturers. Ensuring compliance with global standards demands significant investments in research and development.
  • Integration Issues: Seamless integration of BIS technologies into existing healthcare systems, particularly electronic health records, remains a challenge that requires technological refinement.
  • Technological Constraints: While BIS devices are evolving, achieving consistent precision, scalability, and cost-efficiency remains crucial for long-term market growth.

Regional Insights

  • Europe: Europe leads the BIS market due to its robust healthcare infrastructure and supportive policies. High adoption rates for innovative healthcare technologies position the region as a dominant force in the market.
  • South Asia & Pacific: This region represents the fastest-growing segment in the BIS market. Increasing healthcare awareness and investments in medical technologies are driving adoption, particularly in emerging economies.
  • North America: Advanced healthcare systems and significant investments in R&D place North America as a pivotal region for BIS market expansion.

Recent Innovations

  • 1. Samsung Galaxy Watch: This wearable device includes BIS assessment capabilities, offering consumers a convenient and precise tool for health monitoring.
  • 2. Withings Body Scan Scale: With features like multi-frequency BIS, ECG, and heart rate monitoring, this innovation enhances personalized health diagnostics for consumers.

Leading Companies

Key players in the BIS market include:

  • Tanita Corporation
  • Akern
  • Biodynamics Corporation
  • Samsung
  • Withings
  • ImpediMed Ltd.
  • Omron Corporation

These companies are focusing on innovation, strategic partnerships, and customer-centric solutions to strengthen their market presence.

Market Segmentation

  • By Product: Single Frequency BIS Multiple Frequency BIS
  • By Modality: Hand-held BIA Hand-to-Foot BIA Leg-to-Leg BIA
  • By End User: Hospitals Specialty Clinics Ambulatory Surgical Centers (ASCs) Rehabilitation Centers
  • By Region: North America Europe Asia-Pacific Latin America Middle East & Africa

Table of Contents

1. Executive Summary

  • 1.1. Global Bioimpedance Spectroscopy Market Snapshot
  • 1.2. Future Projections
  • 1.3. Key Market Trends
  • 1.4. Regional Snapshot, by Value and Volume (Units), 2024
  • 1.5. Analyst Recommendations

2. Market Overview

  • 2.1. Market Definitions and Segmentations
  • 2.2. Market Dynamics
    • 2.2.1. Drivers
    • 2.2.2. Restraints
    • 2.2.3. Market Opportunities
  • 2.3. Value Chain Analysis
  • 2.4. Porter's Five Forces Analysis
  • 2.5. COVID-19 Impact Analysis
    • 2.5.1. Supply
    • 2.5.2. Demand
  • 2.6. Impact of Ukraine-Russia Conflict
  • 2.7. Economic Overview
    • 2.7.1. World Economic Projections
  • 2.8. PESTLE Analysis

3. Price Analysis, 2024

  • 3.1. Global Average Price Analysis, by Product, US$ Per Unit, 2019 - 2023
  • 3.2. Prominent Factor Affecting Bioimpedance Spectroscopy Prices
  • 3.3. Global Average Price Analysis, by Region, US$ Per Unit

4. Global Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 4.1. Global Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.1.1. Key Highlights
      • 4.1.1.1. Single Frequency
      • 4.1.1.2. Multiple Frequency
  • 4.2. Global Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 4.2.1. Key Highlights
      • 4.2.1.1. Hand-held BIA
      • 4.2.1.2. Hand-to-Foot BIA
      • 4.2.1.3. Leg-to-Leg BIA
  • 4.3. Global Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 4.3.1. Key Highlights
      • 4.3.1.1. Hospitals
      • 4.3.1.2. Specialty Clinics
      • 4.3.1.3. Ambulatory Surgical Centers
      • 4.3.1.4. Rehabilitation Center
  • 4.4. Global Bioimpedance Spectroscopy Market Outlook, by Region, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 4.4.1. Key Highlights
      • 4.4.1.1. North America
      • 4.4.1.2. Europe
      • 4.4.1.3. Asia Pacific
      • 4.4.1.4. Latin America
      • 4.4.1.5. Middle East & Africa

5. North America Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 5.1. North America Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.1.1. Key Highlights
      • 5.1.1.1. Single Frequency
      • 5.1.1.2. Multiple Frequency
  • 5.2. North America Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 5.2.1. Key Highlights
      • 5.2.1.1. Hand-held BIA
      • 5.2.1.2. Hand-to-Foot BIA
      • 5.2.1.3. Leg-to-Leg BIA
  • 5.3. North America Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 5.3.1. Key Highlights
      • 5.3.1.1. Hospitals
      • 5.3.1.2. Specialty Clinics
      • 5.3.1.3. Ambulatory Surgical Centers
      • 5.3.1.4. Rehabilitation Center
    • 5.3.2. BPS Analysis/Market Attractiveness Analysis
  • 5.4. North America Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 5.4.1. Key Highlights
      • 5.4.1.1. U.S. Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.2. U.S. Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 5.4.1.3. U.S. Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 5.4.1.4. Canada Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 5.4.1.5. Canada Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 5.4.1.6. Canada Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 5.4.2. BPS Analysis/Market Attractiveness Analysis

6. Europe Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 6.1. Europe Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.1.1. Key Highlights
      • 6.1.1.1. Single Frequency
      • 6.1.1.2. Multiple Frequency
  • 6.2. Europe Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 6.2.1. Key Highlights
      • 6.2.1.1. Hand-held BIA
      • 6.2.1.2. Hand-to-Foot BIA
      • 6.2.1.3. Leg-to-Leg BIA
  • 6.3. Europe Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 6.3.1. Key Highlights
      • 6.3.1.1. Hospitals
      • 6.3.1.2. Specialty Clinics
      • 6.3.1.3. Ambulatory Surgical Centers
      • 6.3.1.4. Rehabilitation Center
    • 6.3.2. BPS Analysis/Market Attractiveness Analysis
  • 6.4. Europe Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 6.4.1. Key Highlights
      • 6.4.1.1. Germany Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.2. Germany Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.3. Germany Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.4. U.K. Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.5. U.K. Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.6. U.K. Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.7. France Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.8. France Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.9. France Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.10. Italy Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.11. Italy Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.12. Italy Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.13. Turkey Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.14. Turkey Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.15. Turkey Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.16. Russia Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.17. Russia Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.18. Russia Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 6.4.1.19. Rest of Europe Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 6.4.1.20. Rest of Europe Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 6.4.1.21. Rest of Europe Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 6.4.2. BPS Analysis/Market Attractiveness Analysis

7. Asia Pacific Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 7.1. Asia Pacific Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.1.1. Key Highlights
      • 7.1.1.1. Single Frequency
      • 7.1.1.2. Multiple Frequency
  • 7.2. Asia Pacific Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 7.2.1. Key Highlights
      • 7.2.1.1. Hand-held BIA
      • 7.2.1.2. Hand-to-Foot BIA
      • 7.2.1.3. Leg-to-Leg BIA
  • 7.3. Asia Pacific Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 7.3.1. Key Highlights
      • 7.3.1.1. Hospitals
      • 7.3.1.2. Specialty Clinics
      • 7.3.1.3. Ambulatory Surgical Centers
      • 7.3.1.4. Rehabilitation Center
    • 7.3.2. BPS Analysis/Market Attractiveness Analysis
  • 7.4. Asia Pacific Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 7.4.1. Key Highlights
      • 7.4.1.1. China Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.2. China Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.3. China Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.4. Japan Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.5. Japan Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.6. Japan Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.7. South Korea Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.8. South Korea Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.9. South Korea Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.10. India Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.11. India Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.12. India Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.13. Southeast Asia Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.14. Southeast Asia Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.15. Southeast Asia Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 7.4.1.16. Rest of Asia Pacific Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 7.4.1.17. Rest of Asia Pacific Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 7.4.1.18. Rest of Asia Pacific Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 7.4.2. BPS Analysis/Market Attractiveness Analysis

8. Latin America Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 8.1. Latin America Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.1.1. Key Highlights
      • 8.1.1.1. Single Frequency
      • 8.1.1.2. Multiple Frequency
  • 8.2. Latin America Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 8.2.1. Key Highlights
      • 8.2.1.1. Hand-held BIA
      • 8.2.1.2. Hand-to-Foot BIA
      • 8.2.1.3. Leg-to-Leg BIA
  • 8.3. Latin America Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 8.3.1. Key Highlights
      • 8.3.1.1. Hospitals
      • 8.3.1.2. Specialty Clinics
      • 8.3.1.3. Ambulatory Surgical Centers
      • 8.3.1.4. Rehabilitation Center
    • 8.3.2. BPS Analysis/Market Attractiveness Analysis
  • 8.4. Latin America Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 8.4.1. Key Highlights
      • 8.4.1.1. Brazil Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.2. Brazil Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 8.4.1.3. Brazil Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.4. Mexico Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.5. Mexico Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 8.4.1.6. Mexico Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.7. Argentina Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.8. Argentina Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 8.4.1.9. Argentina Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 8.4.1.10. Rest of Latin America Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 8.4.1.11. Rest of Latin America Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 8.4.1.12. Rest of Latin Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 8.4.2. BPS Analysis/Market Attractiveness Analysis

9. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, 2019 - 2032

  • 9.1. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.1.1. Key Highlights
      • 9.1.1.1. Single Frequency
      • 9.1.1.2. Multiple Frequency
  • 9.2. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, by Modality, Value (US$ Bn, 2019 - 2032
    • 9.2.1. Key Highlights
      • 9.2.1.1. Hand-held BIA
      • 9.2.1.2. Hand-to-Foot BIA
      • 9.2.1.3. Leg-to-Leg BIA
  • 9.3. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, by End User, Value (US$ Bn, 2019 - 2032
    • 9.3.1. Key Highlights
      • 9.3.1.1. Hospitals
      • 9.3.1.2. Specialty Clinics
      • 9.3.1.3. Ambulatory Surgical Centers
      • 9.3.1.4. Rehabilitation Center
    • 9.3.2. BPS Analysis/Market Attractiveness Analysis
  • 9.4. Middle East & Africa Bioimpedance Spectroscopy Market Outlook, by Country, Value (US$ Bn) and Volume (Units), 2019 - 2032
    • 9.4.1. Key Highlights
      • 9.4.1.1. GCC Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.2. GCC Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.3. GCC Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 9.4.1.4. South Africa Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.5. South Africa Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.6. South Africa Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 9.4.1.7. Egypt Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.8. Egypt Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.9. Egypt Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 9.4.1.10. Nigeria Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.11. Nigeria Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.12. Nigeria Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
      • 9.4.1.13. Rest of Middle East & Africa Bioimpedance Spectroscopy Market by Product, Value (US$ Bn) and Volume (Units), 2019 - 2032
      • 9.4.1.14. Rest of Middle East & Africa Bioimpedance Spectroscopy Market by Modality, Value (US$ Bn), 2019 - 2032
      • 9.4.1.15. Rest of Middle East & Africa Bioimpedance Spectroscopy Market by End User, Value (US$ Bn), 2019 - 2032
    • 9.4.2. BPS Analysis/Market Attractiveness Analysis

10. Competitive Landscape

  • 10.1. Company Market Share Analysis, 2024
  • 10.2. Competitive Dashboard
  • 10.3. Company Profiles
    • 10.3.1. Tanita Corporation
      • 10.3.1.1. Company Overview
      • 10.3.1.2. Product Portfolio
      • 10.3.1.3. Financial Overview
      • 10.3.1.4. Business Strategies and Development
    • 10.3.2. Akern
      • 10.3.2.1. Company Overview
      • 10.3.2.2. Product Portfolio
      • 10.3.2.3. Financial Overview
      • 10.3.2.4. Business Strategies and Development
    • 10.3.3. Biodynamics Corporation
      • 10.3.3.1. Company Overview
      • 10.3.3.2. Product Portfolio
      • 10.3.3.3. Financial Overview
      • 10.3.3.4. Business Strategies and Development
    • 10.3.4. Bioparhom
      • 10.3.4.1. Company Overview
      • 10.3.4.2. Product Portfolio
      • 10.3.4.3. Financial Overview
      • 10.3.4.4. Business Strategies and Development
    • 10.3.5. Biotekna
      • 10.3.5.1. Company Overview
      • 10.3.5.2. Product Portfolio
      • 10.3.5.3. Financial Overview
      • 10.3.5.4. Business Strategies and Development
    • 10.3.6. Bodystat Ltd
      • 10.3.6.1. Company Overview
      • 10.3.6.2. Product Portfolio
      • 10.3.6.3. Financial Overview
      • 10.3.6.4. Business Strategies and Development
    • 10.3.7. Charder Electronic Co. Ltd
      • 10.3.7.1. Company Overview
      • 10.3.7.2. Product Portfolio
      • 10.3.7.3. Financial Overview
      • 10.3.7.4. Business Strategies and Development
    • 10.3.8. Evolt 360
      • 10.3.8.1. Company Overview
      • 10.3.8.2. Product Portfolio
      • 10.3.8.3. Financial Overview
      • 10.3.8.4. Business Strategies and Development
    • 10.3.9. Fook Tin Group Holding Ltd
      • 10.3.9.1. Company Overview
      • 10.3.9.2. Product Portfolio
      • 10.3.9.3. Financial Overview
      • 10.3.9.4. Business Strategies and Development
    • 10.3.10. InBody Co. Ltd
      • 10.3.10.1. Company Overview
      • 10.3.10.2. Product Portfolio
      • 10.3.10.3. Financial Overview
      • 10.3.10.4. Business Strategies and Development
    • 10.3.11. Lumsail Industrial Inc.
      • 10.3.11.1. Company Overview
      • 10.3.11.2. Product Portfolio
      • 10.3.11.3. Financial Overview
      • 10.3.11.4. Business Strategies and Development
    • 10.3.12. Maltron International
      • 10.3.12.1. Company Overview
      • 10.3.12.2. Product Portfolio
      • 10.3.12.3. Financial Overview
      • 10.3.12.4. Business Strategies and Development
    • 10.3.13. Omron Corporation
      • 10.3.13.1. Company Overview
      • 10.3.13.2. Product Portfolio
      • 10.3.13.3. Financial Overview
      • 10.3.13.4. Business Strategies and Development
    • 10.3.14. RJL Systems
      • 10.3.14.1. Company Overview
      • 10.3.14.2. Product Portfolio
      • 10.3.14.3. Financial Overview
      • 10.3.14.4. Business Strategies and Development
    • 10.3.15. Seca GmbH & Co. KG
      • 10.3.15.1. Company Overview
      • 10.3.15.2. Product Portfolio
      • 10.3.15.3. Financial Overview
      • 10.3.15.4. Business Strategies and Development

11. Appendix

  • 11.1. Research Methodology
  • 11.2. Report Assumptions
  • 11.3. Acronyms and Abbreviations
샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제